{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T02:07:24Z","timestamp":1750990044786},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,4,21]],"date-time":"2009-04-21T00:00:00Z","timestamp":1240272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-2334-9-46","type":"journal-article","created":{"date-parts":[[2009,4,21]],"date-time":"2009-04-21T18:13:27Z","timestamp":1240337607000},"source":"Crossref","is-referenced-by-count":20,"title":["Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database"],"prefix":"10.1186","volume":"9","author":[{"given":"Jialun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick CK","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poh Lian","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasisopin","family":"Kiertiburanakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagalingeswaran","family":"Kumarasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuti Parwati","family":"Merati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Pujari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ming A","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praphan","family":"Phanuphak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saphonn","family":"Vonthanak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thira","family":"Sirisanthana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somnuek","family":"Sungkanuparph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher KC","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeeba","family":"Kamarulzaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goa","family":"Tau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Ditangco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,21]]},"reference":[{"issue":"6","key":"811_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jama.279.6.450","volume":"279","author":"RS Hogg","year":"1998","unstructured":"Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, et al: Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998, 279 (6): 450-4. 10.1001\/jama.279.6.450.","journal-title":"JAMA"},{"issue":"9377","key":"811_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0140-6736(03)13802-0","volume":"362","author":"A Mocroft","year":"2003","unstructured":"Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, et al: Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003, 362 (9377): 22-9. 10.1016\/S0140-6736(03)13802-0.","journal-title":"Lancet"},{"issue":"3","key":"811_CR3","first-page":"225","volume":"5","author":"M Badri","year":"2001","unstructured":"Badri M, Ehrlich R, Wood R, Pulerwitz T, Maartens G: Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. Int J Tuberc Lung Dis. 2001, 5 (3): 225-32.","journal-title":"Int J Tuberc Lung Dis"},{"key":"811_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1164\/rccm.200405-590OC","volume":"170","author":"EL Corbett","year":"2004","unstructured":"Corbett EL, Charalambous S, Moloi VM, Fielding K, Grant AD, Dye C, et al: Human Immunodeficiency Virus and the Prevalence of Undiagnosed Tuberculosis in African Gold Miners. Am J Respir Crit Care Med. 2004, 170: 673-9. 10.1164\/rccm.200405-590OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"811_CR5","first-page":"277","volume":"120","author":"JP Narain","year":"2004","unstructured":"Narain JP, Lo YR: Epidemiology of HIV-TB in Asia. Indian J Med Res. 2004, 120 (4): 277-89.","journal-title":"Indian J Med Res"},{"issue":"9","key":"811_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","volume":"163","author":"EL Corbett","year":"2003","unstructured":"Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al: The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003, 163 (9): 1009-21. 10.1001\/archinte.163.9.1009.","journal-title":"Arch Intern Med"},{"key":"811_CR7","volume-title":"WHO report 2008","author":"WHO","year":"2008","unstructured":"WHO: Global tuberculosis control: surveillance, planning, financing. WHO report 2008. 2008, (WHO\/HTM\/TB\/2008.393) Geneva: World Health Organization"},{"issue":"9","key":"811_CR8","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1097\/00002030-200006160-00020","volume":"14","author":"CC Whalen","year":"2000","unstructured":"Whalen CC, Nsubuga P, Okwera A, Johnson JL, Hom DL, Michael NL, et al: Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS. 2000, 14 (9): 1219-28. 10.1097\/00002030-200006160-00020.","journal-title":"AIDS"},{"issue":"9323","key":"811_CR9","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","volume":"359","author":"M Badri","year":"2002","unstructured":"Badri M, Wilson D, Wood R: Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet. 2002, 359 (9323): 2059-64. 10.1016\/S0140-6736(02)08904-3.","journal-title":"Lancet"},{"issue":"18","key":"811_CR10","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","volume":"19","author":"SD Lawn","year":"2005","unstructured":"Lawn SD, Badri M, Wood R: Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS. 2005, 19 (18): 2109-16.","journal-title":"AIDS"},{"key":"811_CR11","volume-title":"Geneva","author":"UNAIDS","year":"2008","unstructured":"UNAIDS: Report on the Global AIDS Epidemic. Geneva. 2008"},{"issue":"18","key":"811_CR12","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1097\/00002030-200312050-00008","volume":"17","author":"CC Hung","year":"2003","unstructured":"Hung CC, Chen MY, Hsiao CF, Hsieh SM, Sheng WH, Chang SC: Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy. AIDS. 2003, 17 (18): 2615-22. 10.1097\/00002030-200312050-00008.","journal-title":"AIDS"},{"issue":"14","key":"811_CR13","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1097\/00002030-200309260-00018","volume":"17","author":"S Sungkanuparph","year":"2003","unstructured":"Sungkanuparph S, Vibhagool A, Mootsikapun P, Chetchotisakd P, Tansuphaswaswadikul S, Bowonwatanuwong C: Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis. AIDS. 2003, 17 (14): 2129-31. 10.1097\/00002030-200309260-00018.","journal-title":"AIDS"},{"issue":"6","key":"811_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/01.aids.0000163940.85940.03","volume":"19","author":"N Kumarasamy","year":"2005","unstructured":"Kumarasamy N, Vallabhaneni S, Flanigan TP, Balakrishnan P, Cecelia A, Carpenter CC, et al: Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients. AIDS. 2005, 19 (6): 625-7. 10.1097\/01.aids.0000163940.85940.03.","journal-title":"AIDS"},{"issue":"2","key":"811_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/01.qai.0000145351.96815.d5","volume":"38","author":"J Zhou","year":"2005","unstructured":"Zhou J, Kumarasamy N, Ditangco R, Kamarulzaman A, Lee CK, Li PC, et al: The TREAT Asia HIV Observational Database: Baseline and Retrospective Data. J Acquir Immune Defic Syndr. 2005, 38 (2): 174-9. 10.1097\/01.qai.0000145351.96815.d5.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"811_CR16","volume-title":"A Bi-Regional Report","author":"WHO","year":"2005","unstructured":"WHO: Tuberculosis Control in South-East Asia and Western Pacific Regions 2005. A Bi-Regional Report. 2005, WHO Regional Offices for South-East Asia Region and Western Pacific Region"},{"issue":"9327","key":"811_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","volume":"360","author":"M Egger","year":"2002","unstructured":"Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, et al: Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002, 360 (9327): 119-29. 10.1016\/S0140-6736(02)09411-4.","journal-title":"Lancet"},{"issue":"2","key":"811_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1386-6532(02)00119-1","volume":"26","author":"K Petoumenos","year":"2003","unstructured":"Petoumenos K: The role of observational data in monitoring trends in antiretroviral treatment and HIV disease stage: results from the Australian HIV observational database. J Clin Virol. 2003, 26 (2): 209-22. 10.1016\/S1386-6532(02)00119-1.","journal-title":"J Clin Virol"},{"issue":"3","key":"811_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1468-1293.2005.00292.x","volume":"6","author":"J Zhou","year":"2005","unstructured":"Zhou J, Kumarasamy N: Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: preliminary results from the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2005, 6 (3): 216-23. 10.1111\/j.1468-1293.2005.00292.x.","journal-title":"HIV Med"},{"issue":"10","key":"811_CR20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/003655401317074590","volume":"33","author":"S Jensen-Fangel","year":"2001","unstructured":"Jensen-Fangel S, Pedersen C, Larsen CS, Tauris P, Moller A, Obel N: Changing demographics in an HIV-infected population: results from an observational cohort study in Western Denmark. Scand J Infect Dis. 2001, 33 (10): 765-70. 10.1080\/003655401317074590.","journal-title":"Scand J Infect Dis"},{"issue":"10","key":"811_CR21","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1086\/497267","volume":"41","author":"N Kumarasamy","year":"2005","unstructured":"Kumarasamy N, Solomon S, Chaguturu SK, Cecelia AJ, Vallabhaneni S, Flanigan TP, et al: The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India. Clin Infect Dis. 2005, 41 (10): 1525-8. 10.1086\/497267.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"811_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinf.2003.09.001","volume":"48","author":"SD Lawn","year":"2004","unstructured":"Lawn SD: AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. J Infect. 2004, 48 (1): 1-12. 10.1016\/j.jinf.2003.09.001.","journal-title":"J Infect"},{"issue":"Suppl 3","key":"811_CR23","first-page":"S47","volume":"14","author":"E Girardi","year":"2000","unstructured":"Girardi E, Raviglione MC, Antonucci G, Godfrey-Faussett P, Ippolito G: Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. AIDS. 2000, 14 (Suppl 3): S47-56.","journal-title":"AIDS"},{"issue":"3 Pt 1","key":"811_CR24","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1164\/ajrccm.162.3.9908018","volume":"162","author":"O Kirk","year":"2000","unstructured":"Kirk O, Gatell JM, Mocroft A, Pedersen C, Proenca R, Brettle RP, et al: Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD. Am J Respir Crit Care Med. 2000, 162 (3 Pt 1): 865-72.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"811_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1164\/rccm.200410-1342OC","volume":"172","author":"C Seyler","year":"2005","unstructured":"Seyler C, Toure S, Messou E, Bonard D, Gabillard D, Anglaret X: Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan. Am J Respir Crit Care Med. 2005, 172 (1): 123-7. 10.1164\/rccm.200410-1342OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"811_CR26","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","volume":"21","author":"JE Golub","year":"2007","unstructured":"Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS, et al: The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS. 2007, 21 (11): 1441-8. 10.1097\/QAD.0b013e328216f441.","journal-title":"AIDS"},{"issue":"7","key":"811_CR27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1258\/095646207781147283","volume":"18","author":"J Zhou","year":"2007","unstructured":"Zhou J, Paton NI, Ditangco R: AIDS-defining illness diagnosed within 90 days after starting highly active antiretroviral therapy among patients from the TREAT Asia HIV Observational Database. Int J STD AIDS. 2007, 18 (7): 446-52. 10.1258\/095646207781147283.","journal-title":"Int J STD AIDS"},{"issue":"4","key":"811_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/01.aids.0000161769.06158.8a","volume":"19","author":"SA Shelburne","year":"2005","unstructured":"Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC, et al: Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005, 19 (4): 399-406. 10.1097\/01.aids.0000161769.06158.8a.","journal-title":"AIDS"},{"issue":"12","key":"811_CR29","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1097\/01.aids.0000131375.21070.06","volume":"18","author":"MA French","year":"2004","unstructured":"French MA, Price P, Stone SF: Immune restoration disease after antiretroviral therapy. AIDS. 2004, 18 (12): 1615-27. 10.1097\/01.aids.0000131375.21070.06.","journal-title":"AIDS"},{"issue":"14","key":"811_CR30","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1097\/00002030-199910010-00007","volume":"13","author":"T Wendland","year":"1999","unstructured":"Wendland T, Furrer H, Vernazza PL, Frutig K, Christen A, Matter L, et al: HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia. AIDS. 1999, 13 (14): 1857-62. 10.1097\/00002030-199910010-00007.","journal-title":"AIDS"},{"issue":"9514","key":"811_CR31","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0140-6736(06)68383-9","volume":"367","author":"EL Corbett","year":"2006","unstructured":"Corbett EL, Marston B, Churchyard GJ, De Cock KM: Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet. 2006, 367 (9514): 926-37. 10.1016\/S0140-6736(06)68383-9.","journal-title":"Lancet"},{"key":"811_CR32","volume-title":"Recommendations for a public health approach. 2006 revision. Geneva","author":"WHO","year":"2006","unstructured":"WHO: Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach. 2006 revision. Geneva. 2006"},{"issue":"12","key":"811_CR33","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1086\/498315","volume":"41","author":"E Girardi","year":"2005","unstructured":"Girardi E, Sabin CA, d'Arminio Monforte A, Hogg B, Phillips AN, Gill MJ, et al: Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis. 2005, 41 (12): 1772-82. 10.1086\/498315.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"811_CR34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","volume":"11","author":"MA Hernan","year":"2000","unstructured":"Hernan MA, Brumback B, Robins JM: Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000, 11 (5): 561-70. 10.1097\/00001648-200009000-00012.","journal-title":"Epidemiology"},{"issue":"8","key":"811_CR35","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/155.8.710","volume":"155","author":"K Tilling","year":"2002","unstructured":"Tilling K, Sterne JA, Szklo M: Estimating the effect of cardiovascular risk factors on all-cause mortality and incidence of coronary heart disease using G-estimation: the atherosclerosis risk in communities study. Am J Epidemiol. 2002, 155 (8): 710-8. 10.1093\/aje\/155.8.710.","journal-title":"Am J Epidemiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-9-46\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-46.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-46","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-46.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T06:38:11Z","timestamp":1548139091000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-9-46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,21]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["811"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-9-46","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,21]]},"article-number":"46"}}